The Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) has become the default holding for income-minded investors who want a low-cost basket of U.S. dividend payers. It charges a 0.06% expense ratio, holds roughly $95.1 billion in net assets, and screens for companies with durable dividends and reasonable balance sheets. SCHD owners generally want quarterly checks, a moderate yield, and exposure to mature U.S. businesses without paying an active manager’s fees. On those terms, SCHD has delivered.
The question this article addresses is whether a different dividend ETF has done the same job with a smoother income stream and a stronger total return: the WisdomTree U.S. Quality Dividend Growth Fund (NASDAQ: DGRW).
What SCHD Is Built To Do
SCHD tracks the Dow Jones U.S. Dividend 100 Index, a rules-based screen emphasizing sustainable yield, cash flow to debt, return on equity, and consistent dividend growth. The result is a classic value-tilted, sector-concentrated portfolio. The top ten positions include Texas Instruments at 5.59%, UnitedHealth Group at 5.55%, and Qualcomm at 5.53%. The list continues with stalwarts like Coca-Cola at 4.08%, Chevron at 3.94%, and Merck at 3.90%. Healthcare, energy, consumer staples, and dividend-paying technology leaders dominate the mix, providing a defensive alternative to pure growth.
That construction explains both the appeal and the limitation. SCHD pays a higher headline yield than the broad market, but it earns that yield by underweighting the sectors that have led U.S. equity returns for most of the last decade.
Where The Gap Shows Up
Total return is the cleanest way to measure a dividend ETF, because price appreciation and reinvested distributions both matter to a long-term holder.
Over the trailing five years, SCHD returned 51% on a price-adjusted basis. DGRW returned 74.9% over the same window. Stretched to ten years, SCHD returned 232% against DGRW’s 270%. In calendar 2025, the spread widened: DGRW returned 12.51% while SCHD returned 4.56%.
On a dollar basis, $10,000 placed in each fund five years ago would have grown to roughly $15,080 in SCHD and roughly $17,490 in DGRW before reinvestment differences. The gap reflects DGRW’s tilt toward quality companies with reinvestment runway, not just current payouts.
What DGRW Does Differently
DGRW screens U.S. dividend payers on forward earnings growth expectations and quality factors, specifically three-year average return on equity and return on assets. Companies are then weighted by projected cash dividends rather than market capitalization. The result is a basket with more technology and industrials and less concentration in slow-growth value sectors. It is still a dividend fund, but it leans toward dividend growers rather than current high-yielders.
The income cadence is the other meaningful difference. SCHD pays quarterly. Its recent distributions include $0.2569 paid on March 30, 2026, $0.2782 on December 15, 2025, and $0.2604 on September 29, 2025. DGRW pays monthly. Recent distributions include $0.055 on May 28, 2026, $0.075 on April 29, 2026, $0.17 on March 30, 2026, and $0.055 on February 26, 2026. The monthly schedule has been continuous since at least 2020.
For a retiree drawing income to cover monthly expenses, that change in cadence is structural. Bills arrive monthly. Quarterly dividends require either a cash buffer or a partial sale between payments. Monthly distributions remove that mismatch.
The Honest Tradeoffs
DGRW does not win on every axis, and SCHD holders should see the costs clearly before considering a switch.
The fee gap is the first one. DGRW carries a 0.28% expense ratio, compared with SCHD’s 0.06%. That is roughly 4.5 times the cost. On $100,000 invested, the annual fee difference is about $220. Over a decade of compounding, the drag is real, though the historical total-return gap has more than absorbed it.
The yield gap is the second, as SCHD’s recent quarterly distributions annualize to a higher trailing yield than DGRW’s monthly stream. DGRW yields less than SCHD, and the income-first reader can weigh that accordingly. The DGRW case rests on total return and cadence, not on a richer headline yield.
The third tradeoff is recency. The long-term scoreboard favors DGRW, but the most recent twelve months tell a different story. SCHD returned 25.78% over the trailing year, while DGRW returned 17.86%. Year-to-date 2026, SCHD is up 19.59% versus DGRW’s 7.35%. The value tilt that hurt SCHD in the growth-led years has helped it as energy, healthcare, and defense rerated higher. A switch made at this moment would lock in that gap.
If A Swap Makes Sense
The mechanics depend on the account type. Inside a Roth IRA, traditional IRA, or 401(k), selling SCHD and buying DGRW is a simple rebalance with no tax consequence. In a taxable brokerage account, the position likely carries embedded gains given the five-year run, and a full sale would trigger capital gains tax that could exceed several years of fee savings or yield differential.
A common approach for taxable holders is to stop reinvesting SCHD distributions and direct new contributions into DGRW, letting the allocation drift over time rather than realizing gains all at once. Holders who use the dividends for spending can leave SCHD intact and add DGRW alongside it. The two funds are complementary. SCHD is value-tilted and sector-concentrated; DGRW is quality- and growth-tilted with broader sector exposure. A blend captures both factor exposures.
Where That Leaves The Decision
SCHD remains a rock-solid, low-cost choice for dividend investors, and its value-tilted style has performed quite well over the last year. If you are leaning toward DGRW, the big draw is the monthly payout, which lines up much better with the average retiree’s monthly bills. Plus, high-quality dividend growers have historically delivered better total returns over three, five, and ten-year periods, even after accounting for the higher management fee.
On the flip side, DGRW will give you a lower starting yield, and you will pay more in expenses for the privilege. Its specific strategy has also cooled off a bit compared to the market’s recent pace. At the end of the day, if your main target is total growth and a more consistent monthly check, DGRW is definitely worth a look. However, if your top priority is simply to squeeze the most cash possible from a single fund today, SCHD is still hard to beat.
Top Gaining Stocks
Top Losing Stocks